Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Cencora
COR
$63.2B
| $92.9M | 0.03% |
778,040
+28,273
| +4% | +$3.4M |
|
527
Entegris
ENTG
$22.9B
| $92.9M | 0.03% |
737,634
+22,250
| +3% | +$2.68M |
|
528
Darden Restaurants
DRI
$24.9B
| $92.9M | 0.03% |
613,096
-2,061
| -0.3% | -$303K |
|
529
Trimble
TRMB
$13.4B
| $92.7M | 0.03% |
1,127,049
-528,335
| -32% | -$46.4M |
|
530
Lincoln National
LNC
$8.6B
| $92.2M | 0.03% |
1,341,268
-2,734
| -0.2% | -$179K |
|
531
Steris
STE
$23.4B
| $92M | 0.03% |
450,596
-220,075
| -33% | -$47.1M |
|
532
Dentsply Sirona
XRAY
$2.34B
| $91.9M | 0.03% |
1,583,224
+55,060
| +4% | +$3.39M |
|
|
HOLX
533
DELISTED
Hologic
HOLX
| $91.7M | 0.03% |
1,242,927
-79,442
| -6% | -$5.96M |
|
534
McCormick & Company Non-Voting
MKC
$14.2B
| $91.3M | 0.03% |
1,126,556
+20,993
| +2% | +$1.8M |
|
535
Factset
FDS
$10.1B
| $90.9M | 0.03% |
230,343
+10,891
| +5% | +$3.96M |
|
536
Sonoco
SON
$5.71B
| $90.7M | 0.03% |
1,523,108
+120,460
| +9% | +$7.71M |
|
537
Howmet Aerospace
HWM
$112B
| $90.6M | 0.03% |
2,904,031
+15,328
| +0.5% | +$493K |
|
538
Trade Desk
TTD
$6.29B
| $90.4M | 0.03% |
1,286,320
+28,608
| +2% | +$2.21M |
|
539
Cboe Global Markets
CBOE
$29.4B
| $90.2M | 0.03% |
728,475
+18,239
| +3% | +$2.23M |
|
540
MongoDB
MDB
$35.1B
| $90.2M | 0.03% |
191,313
-80,147
| -30% | -$32.3M |
|
541
Avantor
AVTR
$9.31B
| $90.1M | 0.03% |
2,203,228
-760,717
| -26% | -$29.7M |
|
542
Tetra Tech
TTEK
$9.11B
| $89.8M | 0.03% |
3,006,570
-10,540
| -0.3% | -$289K |
|
543
HubSpot
HUBS
$11B
| $89.5M | 0.03% |
132,320
-90,934
| -41% | -$58.6M |
|
544
Intellia Therapeutics
NTLA
$1.67B
| $89.5M | 0.03% |
666,822
+209,525
| +46% | +$31.7M |
|
545
Cardinal Health
CAH
$56.1B
| $89.4M | 0.03% |
1,807,180
+45,137
| +3% | +$2.45M |
|
546
Domino's
DPZ
$11.9B
| $88.8M | 0.03% |
186,112
-5,137
| -3% | -$2.6M |
|
547
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$847M
| $88.6M | 0.03% |
3,469,672
+155,674
| +5% | +$3.98M |
|
548
Dell
DELL
$284B
| $88.6M | 0.03% |
1,679,643
+187,035
| +13% | +$9.32M |
|
549
Broadridge
BR
$19.4B
| $88.5M | 0.03% |
531,253
+7,736
| +1% | +$1.32M |
|
550
Quest Diagnostics
DGX
$26.3B
| $88.4M | 0.03% |
608,638
-22,880
| -4% | -$3.35M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.